 | Up a level |
Boller, Danielle; Doepfner, Kathrin T; Laurentiis, Angela DE; Guerreiro, Ana S; Marinov, Marin; Shalaby, Tarek; Depledge, Paul; Robson, Anthony; Saghir, Nahid; Hayakawa, Masahiko; Kaizawa, Hiroyuki; Koizumi, Tomonobu; Ohishi, Takahide; Fattet, Sarah; Delattre, Olivier; Schweri-Olac, Anelia; Höland, Katrin; Grotzer, Michael A; Frei, Karl; Spertini, Olivier; ... (2022). Republication: Targeting PI3KC2β Impairs Proliferation and Survival in Acute Leukemia, Brain Tumours and Neuroendocrine Tumours. Anticancer research, 42(6), pp. 3217-3230. International Inst. of Anticancer Research 10.21873/anticanres.15812
Boller, Danielle; Doepfner, Kathrin T; De Laurentiis, Angela; Guerreiro, Ana S; Marinov, Marin; Shalaby, Tarek; Depledge, Paul; Robson, Anthony; Saghir, Nahid; Hayakawa, Masahiko; Kaizawa, Hiroyuki; Koizumi, Tomonobu; Ohishi, Takahide; Fattet, Sarah; Delattre, Olivier; Schweri-Olac, Anelia; Höland, Katrin; Grotzer, Michael A; Frei, Karl; Spertini, Olivier; ... (2012). Targeting PI3KC2β impairs proliferation and survival in acute leukemia, brain tumours and neuroendocrine tumours. Anticancer research, 32(8), pp. 3015-27. Kapandriti: International Inst. of Anticancer Research
Guerreiro, Ana S; Fattet, Sarah; Kulesza, Dorota W; Atamer, Abdullah; Elsing, Alexandra N; Shalaby, Tarek; Jackson, Shaun P; Schoenwaelder, Simone M; Grotzer, Michael A; Delattre, Olivier; Arcaro, Alexandre (2011). A sensitized RNA interference screen identifies a novel role for the PI3K p110γ isoform in medulloblastoma cell proliferation and chemoresistance. Molecular cancer research, 9(7), pp. 925-35. Philadelphia, Pa.: American Association for Cancer Research AACR 10.1158/1541-7786.MCR-10-0200
